ArticleslgStudy

biology

Mene Pangalos

Mene Pangalos is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Mene Pangalos rather than just read about it. In short: Sir Menelaos (Mene) Nicolas Pangalos (Greek: Μενέλαος Νικόλας Πάγκαλος) is a British neuroscientist of Greek descent. Pangalos is Executive Vice President, BioPharmaceuticals R&D at AstraZeneca.

Key takeaways

  • Mene Pangalos belongs to biology; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Mene Pangalos to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Mene Pangalos from memory before moving on to harder problems.

Reference excerpt

Sir Menelaos (Mene) Nicolas Pangalos (Greek: Μενέλαος Νικόλας Πάγκαλος) is a British neuroscientist of Greek descent. Pangalos is Executive Vice President, BioPharmaceuticals R&D at AstraZeneca. He is responsible for the company's research and development of new drugs to treat respiratory, inflammation and autoimmune, renal, cardiovascular and metabolic diseases. Pangalos is the author of over 150 peer-reviewed articles published in scientific journals and serves on the board of the Francis Crick Institute, Cambridge Judge Business School and Dizal Pharma. He is a Fellow of the Royal Society and sits on their Science, Industry & Translation Committee. Pangalos was knighted in the 2020 New Year Honours for services to UK science.

Early life and education Pangalos was born in Ealing, London, to a family of Greek diaspora which settled in England. His parents were from the island of Chios and his mother (née Psarros) was also born there. His extended family on both parents' sides still live in Chios and he spent childhood summers there. He is fluent in Greek. He commenced his scientific studies with a Bachelor of Science in Biochemistry and Molecular Biology (First Class Honours) from Imperial College London and a subsequent Ph.D. in neuropharmacology from University College London. His post-doctoral training was conducted under the tutelage of Prof. N. K. Robakis at the Mount Sinai Medical Center, New York.

Pharmaceutical industry career Pangalos previously served as Group Director and Head of Neurodegenerative Research at GlaxoSmithKline in Harlow, United Kingdom, and has held positions with SmithKline Beecham, Janssen Pharmaceutica and Bristol-Myers Squibb.

Wyeth Pangalos was the Vice President of Neuroscience Research at American pharmaceutical company Wyeth from 2003 to 2008. He was responsible for overseeing the transition of more than 20 novel drug candidates into clinical development for a number of neurological and psychiatric diseases including Alzheimer's disease, stroke, schizophrenia, and pain.

Pfizer In April, 2009, Pfizer announced that Pangalos would serve as the Chief Scientific Officer for Neuroscience, and that the role would be effective when the merger of Wyeth and Pfizer completed in 4Q, 2009. His time with Pfizer was brief, since Pangalos joined Astra Zeneca in 2010. According to Pangalos' linked-in profile, Pangalos was Senior Vice President at Pfizer from 2008 to 2010. He was responsible for 200 scientists and clinicians taking Pfizer neuroscience programmes from target identification through to proof of concept.

AstraZeneca Pangalos was appointed Executive Vice President, BioPharmaceuticals R&D at AstraZeneca in January 2019. He previously held the role of Executive Vice President, Innovative Medicines & Early Clinical Development (IMED) Biotech Unit of AstraZeneca from April 2010 to December 2018. Since Pangalos has been working at AstraZeneca, the company's compound success rate from pre-clinical studies to launch has increased from 4% to >19%. This is above the pharmaceutical industry average of 6%. He has led the discovery and development of some of the pharmaceutical industry's fastest-to-market drugs, moving them from first-in-human trials to launch in just over 2.5 years. One notable example, the EGFRm inhibitor osimertinib for non-small cell lung cancer (NSCLC), is now approved in over 75 countries. Pangalos is on the AstraZeneca Senior Executive Team and is the Executive Chair of the AstraZeneca Board Science Committee. In May 2020, amid the COVID-19 pandemic, he was appointed to the expert advisory group for the UK Government's Vaccine Task Force, chaired by Patrick Vallance.

Academic career Pangalos was elected a Fellow of the Royal Society in May 2022. He is also a Fellow of the Academy of Medical Sciences, the Royal Society of Biology and Clare Hall, University of Cambridge. He sits on the council of the Medical Research Council (MRC), co-chairs the Life Sciences Council Expert Group on Innovation, Clinical Research and Data and is a member of the UK Life Sciences Industrial Strategy Implementation Board. Pangalos has held Visiting Professorships at the University of Pennsylvania and King's College London. He is on the editorial boards of a number of scientific journals – Molecular and Cellular Neuroscience, Neuropharmacology and The Scientific World and is on scientific advisory boards for the Wolfson Centre for Age-Related Diseases (King's College London University) and Rider University. Pangalos has edited the book Understanding G protein-coupled receptors and their role in the central nervous system (CNS), and a number of journal issues focused on drug discovery in the CNS. He also mentors post-doc and PhD students in his role at AstraZeneca.

Personal life Pangalos married Kelly Charles, a fellow neuroscientist, in 2003 in Hertfordshire, England.

References

Worked examples

Example 1 — a first encounter with Mene Pangalos

Start with the simplest possible case. Write down what Mene Pangalos claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Mene Pangalos before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Mene Pangalos ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Mene Pangalos

In research
Mene Pangalos appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Mene Pangalos in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Mene Pangalos is common in secondary-school and first-year university syllabi. It links to neighbouring topics Academics of King's College London, Alumni of Imperial College London, Alzheimer's disease researchers, so understanding it makes those chapters shorter.
In everyday life
Look for Mene Pangalos outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.
Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Mene Pangalos” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Mene Pangalos in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Mene Pangalos means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Mene Pangalos out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Mene Pangalos in simple terms?

Sir Menelaos (Mene) Nicolas Pangalos (Greek: Μενέλαος Νικόλας Πάγκαλος) is a British neuroscientist of Greek descent. Pangalos is Executive Vice President, BioPharmaceuticals R&D at AstraZeneca.

Why does Mene Pangalos matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Mene Pangalos?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Mene Pangalos.

Tags

  • Academics of King's College London
  • Alumni of Imperial College London
  • Alzheimer's disease researchers
  • AstraZeneca people
  • British fellows of the Royal Society
  • English neuroscientists
  • English people of Greek descent
  • Fellows of the Academy of Medical Sciences (United Kingdom)
  • Knights Bachelor
  • Living people
  • Scientists from London
  • University of Pennsylvania faculty

Keep exploring